PR

BENTONVILLE AR – Glucose Health, Inc. (OTC: “GLUC” “Company”) has raised $460,000 from a group which includes sophisticated beverage industry angel investors. A portion of the $460,000 investment proceeds, received in the Company’s bank account last week, was immediately deployed for full and final payment of a $165,365 dilutive “convertible to equity” debt security, which originated from convertible promissory note financings entered into by GLUC, beginning in fiscal year 2013.  

 

CEO Murray Fleming stated, “sophisticated beverage industry

BENTONVILLE AR – New sales statistics show GLUCODOWN®, manufactured by Glucose Health, Inc. (OTC: GLUC) (“Company”), is benefiting from increasing consumer awareness, early in 2019. Sales of GLUCODOWN® at Walmart pharmacies are up 27% for the first seven weeks of 2019 vs. the first seven weeks of 2018. Even more impressive is the 27% sales increase in 2019 is measured against a Walmart price “Rollback” in the same period of 2018 (which began the liquidation of the first generation of GLUCODOWN®).  Glucose Health, Inc. expects Walmart sales of GLUCODOWN® to continue to increase